Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

MannKind Q4 Sales $12.52M Down From $18.44M YoY

MannKind (NASDAQ:MNKD) reported $12.52 million in sales this quarter. This is a 32.14 percent decrease over sales of $18.44 million the same period last year.
byBenzinga Newsdesk
February 24, 2022
1 minute read
Total
0
Shares
0
0
0
0
0
0

MannKind (NASDAQ:MNKD) reported $12.52 million in sales this quarter. This is a 32.14 percent decrease over sales of $18.44 million the same period last year.

 
Total
0
Shares
Share 0
Tweet 0
Share 0
Share 0
Share 0
Share 0
Related Posts
Read More

Why Moderna Shares Are Rising

By Henry Khederian
Today, 5:58 AM
Moderna Inc (NASDAQ: MRNA) shares are trading higher by 3.8% at $457.32 amid strength in vaccine names. FDA authorization of a booster shot from competitors BioNTech and Pfizer has possibly lifted sector sentiment as well.

MRNA